Reply: Can treprostinil-induced early gastrointestinal side effects serve as predictors of pulmonary arterial hypertension prognosis?

Int J Cardiol. 2018 Aug 1:264:188. doi: 10.1016/j.ijcard.2018.03.130.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antihypertensive Agents
  • Epoprostenol* / analogs & derivatives
  • Familial Primary Pulmonary Hypertension
  • Humans
  • Hypertension, Pulmonary*
  • Prognosis
  • Treatment Outcome

Substances

  • Antihypertensive Agents
  • Epoprostenol
  • treprostinil